Showing results (11-20 of 588) with videos related to
Sort By:
Pageof 59
Journal of the National Cancer Institute. Monographs|November 2, 2011
Biomarkers predicting clinical benefit: fact or fiction?Valentina Guarneri, Elena Barbieri, Pierfranco ConteSeminars in Oncology|May 23, 2002
Pemetrexed: a promising new treatment for breast cancerJoyce A O'Shaughnessy, Alessandra Gennari, PierFranco ConteDrugs|July 12, 2013
Relapsed triple-negative breast cancer: challenges and treatment strategiesValentina Guarneri, Maria Vittoria Dieci, Pierfranco ConteExpert Opinion on Pharmacotherapy|January 24, 2012
Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancerValentina Guarneri, Maria Vittoria Dieci, Pierfranco ConteCancer Treatment Reviews|June 1, 2014
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsEmilio Bria, Luisa Carbognin, Jenny Furlanetto, et al.Expert Opinion on Investigational Drugs|July 18, 2012
Sorafenib for lung cancer: is the "Battle" still open?Emilio Bria, Sara Pilotto, Giampaolo TortoraThe Oncologist|September 18, 2013
Effects of sulfonylureas on tumor growth: a review of the literatureGiulia Pasello, Loredana Urso, Pierfranco Conte, et al.Expert Review of Anticancer Therapy|March 28, 2018
Olaparib for the treatment of breast cancerGaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri, et al.Transplantation|May 9, 2009
Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versaMassimo Dominici, Paolo Paolucci, Pierfranco Conte, et al.Cancer|September 9, 2005
Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studiesAlessandra Gennari, PierFranco Conte, Riccardo Rosso, et al.Pageof 59